Explore
Trendline
Charter Communications Reports 1% Revenue Decline in Q1 2026 Amidst Shifts in Business Segments
Charter Communications Reports 1% Revenue Decline in Q1 2026 Amidst Shifts in Business Segments
Read More
Trendline
M/I Homes Reports Decrease in First Quarter 2026 Revenue Amid Market Challenges
M/I Homes Reports Decrease in First Quarter 2026 Revenue Amid Market Challenges
Read More
Trendline
Escalade Schedules First Quarter 2026 Financial Results Conference Call
Escalade Schedules First Quarter 2026 Financial Results Conference Call
Read More
Trendline
Galderma's First Quarter 2026 Sales Surge with Innovative Dermatology Products
Galderma's First Quarter 2026 Sales Surge with Innovative Dermatology Products
Read More
Trendline
Sartorius Stedim Biotech Reports Strong Q1 2026 Financial Results
Sartorius Stedim Biotech Reports Strong Q1 2026 Financial Results
Read More
Trendline
IBM Reports Strong First-Quarter Results with Revenue and Profit Growth
IBM Reports Strong First-Quarter Results with Revenue and Profit Growth
Read More
Trendline
Shore Bancshares Reports Record Net Income for Q1 2026 Amid Interest Rate Changes
Shore Bancshares Reports Record Net Income for Q1 2026 Amid Interest Rate Changes
Read More
Trendline
Stewart Information Services Reports Strong Q1 2026 Financial Results Amid Market Volatility
Stewart Information Services Reports Strong Q1 2026 Financial Results Amid Market Volatility
Read More
Trendline
M/I Homes Reports Decline in First Quarter 2026 Revenue Amid Market Challenges
M/I Homes Reports Decline in First Quarter 2026 Revenue Amid Market Challenges
Read More
Trendline
First Reliance Bancshares Reports Significant Income Growth in Q1 2026
First Reliance Bancshares Reports Significant Income Growth in Q1 2026
Read More
Trendline
Danone's Q1 Sales Growth Slows Amid Infant Formula Recall and Middle East Conflict
Danone's Q1 Sales Growth Slows Amid Infant Formula Recall and Middle East Conflict
Read More
Trendline
Medpace Reports Strong Q1 CY2026 Sales but Stock Falls 19.8% Despite Beating Estimates
Medpace Reports Strong Q1 CY2026 Sales but Stock Falls 19.8% Despite Beating Estimates
Read More